JYOTI D PATEL

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology CHICAGO, IL NPI 1083649792

General Payments — all program years on this page

$182,397.43

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 151
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $30,395.89 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $9,749.594
Eli Lilly and Company $7,700.001
EMD Serono, Inc. $4,750.001
Janssen Biotech, Inc. $3,252.402
AstraZeneca UK Limited $1,712.501
Merck Sharp & Dohme Corporation $1,547.055
ARRAY BIOPHARMA INC $1,490.732
ABBVIE INC. $105.623
Regeneron Healthcare Solutions, Inc. $88.002

By program year

Program yearAmountRecords
2018 $29,774.4940
2019 $14,625.0517
2020 $23,974.8312
2021 $12,887.2110
2022 $34,919.5121
2023 $35,820.4530
2024 $30,395.8921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078576122 Janssen Biotech, Inc. $3,150.00 12/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078579357 Janssen Biotech, Inc. $102.40 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093959129 AstraZeneca UK Limited $1,712.50 07/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104202017 AstraZeneca Pharmaceuticals LP $2,460.00 12/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104677031 AstraZeneca Pharmaceuticals LP $107.09 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105195182 ABBVIE INC. $19.00 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105195184 ABBVIE INC. $56.80 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105195186 ABBVIE INC. $29.82 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105487353 AstraZeneca Pharmaceuticals LP $4,100.00 11/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105799747 AstraZeneca Pharmaceuticals LP $3,082.50 02/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114132414 Regeneron Healthcare Solutions, Inc. $59.00 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114132416 Regeneron Healthcare Solutions, Inc. $29.00 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120280222 EMD Serono, Inc. $4,750.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131591928 ARRAY BIOPHARMA INC $1,440.00 10/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1131605334 ARRAY BIOPHARMA INC $50.73 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135091959 Eli Lilly and Company $7,700.00 03/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141605234 Merck Sharp & Dohme LLC $381.25 09/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141605236 Merck Sharp & Dohme LLC $381.25 09/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141605238 Merck Sharp & Dohme LLC $381.25 09/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141715242 Merck Sharp & Dohme LLC $22.05 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141839121 Merck Sharp & Dohme LLC $381.25 09/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.